Spermosens announces positive results from ongoing clinical study
Spermosens AB ("Spermosens" or the "Company") is pleased to announce the first interim results from its ongoing clinical study aimed at validating the diagnostic value of the patented JUNO-Checked system. The study is progressing as planned, and the first results are now being presented according to schedule. The first interim results from the clinical study show a positive correlation between higher JUNO scores, which measure the sperm cells' binding capacity to the egg, and increased fertilization rates and pregnancy outcomes following IVF treatments. JUNO-Checked, the first-ever method to